SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-20-082611
Filing Date
2020-03-23
Accepted
2020-03-23 17:00:36
Documents
2
Group Members
GREGORY GRUNBERGJULIET TAMMENOMS BAKKERLONGITUDE CAPITAL PARTNERS IV, LLCLONGITUDE VENTURE PARTNERS II, L.P.LONGITUDE VENTURE PARTNERS IV, L.P.PATRICK G. ENRIGHT

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d898315dsc13da.htm SC 13D/A 139596
2 EX-99.7 d898315dex997.htm EX-99.7 8226
  Complete submission text file 0001193125-20-082611.txt   149613
Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453
Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252
Kala Pharmaceuticals, Inc. (Subject) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90054 | Film No.: 20735525
SIC: 2834 Pharmaceutical Preparations

Mailing Address 800 EL CAMINO REAL SUITE 220 MENLO PARK CA 94025
Business Address 800 EL CAMINO REAL SUITE 220 MENLO PARK CA 94025 650-854-5700
Longitude Capital Partners II, LLC (Filed by) CIK: 0001647491 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A